Orticumab (Anti-oxLDL)

製品コード：A2386 Batch: A238601

Orticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL). Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.

製品説明

CAS No.	1314241-10-5
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype	Human IgG1
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping	Shipped under low temperature conditions
Purity	99%
Protein concentration	7.178mg/ml
Endotoxin Level	＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。